Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$3.32B |
| 2 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$975M |
| 3 |
AABA
Altaba Inc
AABA
|
+$871M |
| 4 |
VXX
iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019
VXX
|
+$372M |
| 5 |
State Street Utilities Select Sector SPDR ETF
XLU
|
+$338M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.62B |
| 2 |
State Street Industrial Select Sector SPDR ETF
XLI
|
+$1.02B |
| 3 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$860M |
| 4 |
Microsoft
MSFT
|
+$594M |
| 5 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$517M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 6.12% |
| 2 | Healthcare | 4.92% |
| 3 | Financials | 4.07% |
| 4 | Consumer Discretionary | 3.64% |
| 5 | Communication Services | 3.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
826
CALL
Alnylam Pharmaceuticals
ALNY
$28.9B
| $13M | 0.01% |
162,600
+113,600
| +232% | +$7.26M |
|
827
PUT
UnitedHealth
UNH
$378B
| $12.9M | 0.01% |
69,800
-64,500
| -48% | -$11.3M |
|
828
CALL
Altria Group
MO
$114B
| $12.9M | 0.01% |
173,500
+102,100
| +143% | +$7.47M |
|
829
PUT
State Street Materials Select Sector SPDR ETF
XLB
$8.3B
| $12.9M | 0.01% |
480,000
+201,600
| +72% | +$5.35M |
|
830
Hasbro
HAS
$13.2B
| $12.9M | 0.01% |
115,588
+15,541
| +16% | +$1.6M |
|
831
CALL
TripAdvisor
TRIP
$1.65B
| $12.8M | 0.01% |
335,200
+157,800
| +89% | +$6.53M |
|
832
PUT
Direxion Daily Energy Bull 2X ETF
ERX
$230M
| $12.8M | 0.01% |
50,910
+48,480
| +1,995% | +$13.5M |
|
|
WCG
833
DELISTED
Wellcare Health Plans, Inc.
WCG
| $12.7M | 0.01% |
70,980
+13,607
| +24% | +$2.25M |
|
|
EQC
834
DELISTED
Equity Commonwealth
EQC
| $12.7M | 0.01% |
402,808
+106,964
| +36% | +$3.38M |
|
835
PUT
WisdomTree India Earnings Fund ETF
EPI
$2.04B
| $12.7M | 0.01% |
518,200
-2,600
| -0.5% | -$64.5K |
|
|
SWP
836
DELISTED
Stanley Black & Decker, Inc. Corporate Units
SWP
| $12.6M | 0.01% |
+115,247
| New | +$12.2M |
|
837
Qorvo
QRVO
$7.87B
| $12.6M | 0.01% |
199,423
+75,951
| +62% | +$5.43M |
|
|
RSX
838
PUT
DELISTED
VanEck Russia ETF
RSX
| $12.6M | 0.01% |
657,600
+192,200
| +41% | +$3.84M |
|
839
Chemours
CC
$2.54B
| $12.6M | 0.01% |
331,608
+244,989
| +283% | +$9.66M |
|
840
CALL
VanEck Junior Gold Miners ETF
GDXJ
$7B
| $12.5M | 0.01% |
373,300
-286,500
| -43% | -$9.54M |
|
841
PUT
Capital One
COF
$132B
| $12.5M | 0.01% |
150,800
+90,200
| +149% | +$7.33M |
|
842
CALL
Domino's
DPZ
$11.9B
| $12.4M | 0.01% |
58,600
+55,000
| +1,528% | +$10.9M |
|
843
iShares MSCI South Korea ETF
EWY
$22.8B
| $12.4M | 0.01% |
182,654
-1,396
| -0.8% | -$90.7K |
|
844
CALL
Direxion Daily Small Cap Bull 3x ETF
TNA
$1.38B
| $12.4M | 0.01% |
221,700
+68,700
| +45% | +$3.67M |
|
845
Expeditors International
EXPD
$22B
| $12.3M | 0.01% |
218,517
+47,550
| +28% | +$2.62M |
|
846
Intercontinental Exchange
ICE
$85.2B
| $12.3M | 0.01% |
187,198
-8,181
| -4% | -$502K |
|
|
XEC
847
DELISTED
CIMAREX ENERGY CO
XEC
| $12.3M | 0.01% |
130,898
+58,278
| +80% | +$6.42M |
|
848
Edwards Lifesciences
EW
$50.8B
| $12.3M | 0.01% |
312,000
-130,980
| -30% | -$4.78M |
|
849
Nice
NICE
$5.88B
| $12.3M | 0.01% |
156,047
-17,540
| -10% | -$1.3M |
|
850
Celanese
CE
$4.87B
| $12.3M | 0.01% |
129,170
+79,010
| +158% | +$7.04M |
|
Similar funds
Barclays's Q2 2017 Portfolio in Review
As of Q2 2017, Barclays held 7,324 positions worth $93.4B, up 1.6% from $91.9B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Barclays's Q2 2017 filing shows 436 new, 3,303 increased, 2,734 reduced and 395 closed positions. Its largest new stake was Altaba Inc: 16,007,195 shares worth $872M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.62B.
By sector, the portfolio is most concentrated in Technology at 6.1% of assets, up from 5.7% a quarter earlier, followed by Healthcare and Financials.
- Barclays's largest Q2 2017 buy was Altaba Inc: 16,007,195 shares worth $872M.
- Barclays added most to Invesco QQQ Trust in Q2 2017, an estimated $3.32B increase.
- Barclays's biggest Q2 2017 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.62B.
- Barclays fully exited Yahoo Inc in Q2 2017, selling an estimated $174M.
- Barclays's ten largest holdings make up 32% of its $93.4B portfolio in Q2 2017.
- Barclays opened 436 new positions and closed 395 in Q2 2017.
- Barclays's portfolio value rose 1.6% quarter-over-quarter to $93.4B.
Based on Barclays's 13F filing for Q2 2017, filed 14 Aug 2017.